메뉴 건너뛰기
Alimentary Pharmacology and Therapeutics
Volumn 37, Issue 1, 2013, Pages 162-163
Letter: Successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD - Authors' reply
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; IMMUNOSUPPRESSIVE AGENT;
EID: 84870624981     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12125     Document Type: Letter
Times cited : (7)
References (7)
  • 1
    • 84870624981 scopus 로고    scopus 로고
    • Letter: Successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD
    • Beswick L, Hair CS, Dowling D,. Letter: successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD. Aliment Pharmacol Ther 2013; 37: 162.
    • (2013) Aliment Pharmacol Ther , vol.37 , pp. 162
    • Beswick, L.1    Hair, C.S.2    Dowling, D.3
  • 2
    • 60349108861 scopus 로고    scopus 로고
    • Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
    • Hindorf U, Johansson M, Eriksson A, Kvifors E, Almer SH,. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009; 29: 654-61.
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 654-661
    • Hindorf, U.1    Johansson, M.2    Eriksson, A.3    Kvifors, E.4    Almer, S.H.5
  • 3
    • 33745650894 scopus 로고    scopus 로고
    • Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
    • Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S,. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 331-42.
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 331-342
    • Hindorf, U.1    Lindqvist, M.2    Hildebrand, H.3    Fagerberg, U.4    Almer, S.5
  • 4
    • 48449089140 scopus 로고    scopus 로고
    • Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis
    • Bermejo F, Lopez-Sanroman A, Taxonera C, et al,. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther 2008; 28: 623-8.
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 623-628
    • Bermejo, F.1    Lopez-Sanroman, A.2    Taxonera, C.3
  • 5
    • 60649106530 scopus 로고    scopus 로고
    • 6-Thioguanine therapy in Crohn's disease-observational data in Swedish patients
    • Almer SH, Hjortswang H, Hindorf U,. 6-Thioguanine therapy in Crohn's disease-observational data in Swedish patients. Dig Liver Dis 2009; 41: 194-200.
    • (2009) Dig Liver Dis , vol.41 , pp. 194-200
    • Almer, S.H.1    Hjortswang, H.2    Hindorf, U.3
  • 6
    • 33846266585 scopus 로고    scopus 로고
    • Toxicity of 6-thioguanine: No hepatotoxicity in a series of IBD patients treated with longterm, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?
    • Gilissen LP, Derijks LJ, Driessen A, et al,. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with longterm, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects? Dig Liver Dis 2007; 39: 156-9.
    • (2007) Dig Liver Dis , vol.39 , pp. 156-159
    • Gilissen, L.P.1    Derijks, L.J.2    Driessen, A.3
  • 7
    • 38049079278 scopus 로고    scopus 로고
    • Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients
    • de Boer NK, Zondervan PE, Gilissen LP, et al,. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients. Dig Liver Dis 2008; 40: 108-13.
    • (2008) Dig Liver Dis , vol.40 , pp. 108-113
    • De Boer, N.K.1    Zondervan, P.E.2    Gilissen, L.P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.